Development and validation of a prognostic model and risk calculator for the estimation of bipolar-spectrum disorder risk in hospitalised adolescents with non-psychotic/non-bipolar mental disorders.

IF 10.1 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Gonzalo Salazar de Pablo, Joaquim Radua, Grace Frearson, Allan H Young, Celso Arango, Ian Kelleher, Aditya Sharma, Peter J Uhlhaas, Marco Solmi, Paolo Fusar-Poli, Daniel Guinart, Christoph U Correll
{"title":"Development and validation of a prognostic model and risk calculator for the estimation of bipolar-spectrum disorder risk in hospitalised adolescents with non-psychotic/non-bipolar mental disorders.","authors":"Gonzalo Salazar de Pablo, Joaquim Radua, Grace Frearson, Allan H Young, Celso Arango, Ian Kelleher, Aditya Sharma, Peter J Uhlhaas, Marco Solmi, Paolo Fusar-Poli, Daniel Guinart, Christoph U Correll","doi":"10.1038/s41380-025-03244-1","DOIUrl":null,"url":null,"abstract":"<p><p>We aimed to develop and validate a risk estimation model for developing bipolar-spectrum disorders (BSD) in psychiatrically hospitalized adolescents based on clinical characteristics, including putatively prodromal symptoms. Adolescent inpatients (ages = 12-18 years) with non-psychotic/non-BSD diagnoses were recruited for the Adolescent Mood Disorder and Psychosis Study (AMDPS), a longitudinal, prospective 5-year follow-up cohort. We assessed prevalence and severity of syndromal/subsyndromal psychopathology at baseline using the validated Bipolar Prodrome Symptom Interview and Scale-Prospective. We carried out machine learning analyses (Lasso-Cox regression analyses, LCR) to create a calculator to estimate the risk of developing BSD based on baseline demographic/comorbidity/illness/treatment characteristics. Of 105 adolescents (age = 15.6 ± 1.3 years, females = 72.4%), we observed that 18 developed BSD. The cumulated estimated risk of BSD was 5/22/29/36% at 1/2/3/4 years. BSD development was associated with presence of persistent depressive disorder (HR = 4.0, p < 0.018) at baseline, treatment with mood stabilizers (hazard ratio (HR) = 3.9, p = 0.006), and ADHD medications (HR = 3.3, p = 0.023). BSD development risk estimation calculator included the prevalence of inflated self-esteem/grandiosity (β = 0.83) and racing thoughts (β = 0.08) and the severity of overtalkativeness (β = 0.03) and increased energy (β = 0.04). For predicting BSD onset within the first 20 months, the area under the receiver operating characteristic curve (AUC) indicated acceptable to strong discrimination (cross-validation AUC = 0.72; bootstrap out-of-bag validation AUC = 0.86). Codes used in this study are provided in the R package \"easy.glmnet\". In conclusion, in this prognostic model/calculator, presence and severity of subthreshold (hypo)mania-like symptoms conferred increased risk of BSD development in youth, informing preventive efforts to identify individuals at risk for BSD and improve their outcomes.</p>","PeriodicalId":19008,"journal":{"name":"Molecular Psychiatry","volume":" ","pages":""},"PeriodicalIF":10.1000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41380-025-03244-1","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We aimed to develop and validate a risk estimation model for developing bipolar-spectrum disorders (BSD) in psychiatrically hospitalized adolescents based on clinical characteristics, including putatively prodromal symptoms. Adolescent inpatients (ages = 12-18 years) with non-psychotic/non-BSD diagnoses were recruited for the Adolescent Mood Disorder and Psychosis Study (AMDPS), a longitudinal, prospective 5-year follow-up cohort. We assessed prevalence and severity of syndromal/subsyndromal psychopathology at baseline using the validated Bipolar Prodrome Symptom Interview and Scale-Prospective. We carried out machine learning analyses (Lasso-Cox regression analyses, LCR) to create a calculator to estimate the risk of developing BSD based on baseline demographic/comorbidity/illness/treatment characteristics. Of 105 adolescents (age = 15.6 ± 1.3 years, females = 72.4%), we observed that 18 developed BSD. The cumulated estimated risk of BSD was 5/22/29/36% at 1/2/3/4 years. BSD development was associated with presence of persistent depressive disorder (HR = 4.0, p < 0.018) at baseline, treatment with mood stabilizers (hazard ratio (HR) = 3.9, p = 0.006), and ADHD medications (HR = 3.3, p = 0.023). BSD development risk estimation calculator included the prevalence of inflated self-esteem/grandiosity (β = 0.83) and racing thoughts (β = 0.08) and the severity of overtalkativeness (β = 0.03) and increased energy (β = 0.04). For predicting BSD onset within the first 20 months, the area under the receiver operating characteristic curve (AUC) indicated acceptable to strong discrimination (cross-validation AUC = 0.72; bootstrap out-of-bag validation AUC = 0.86). Codes used in this study are provided in the R package "easy.glmnet". In conclusion, in this prognostic model/calculator, presence and severity of subthreshold (hypo)mania-like symptoms conferred increased risk of BSD development in youth, informing preventive efforts to identify individuals at risk for BSD and improve their outcomes.

非精神病性/非双相精神障碍住院青少年双相谱系障碍风险评估的预后模型和风险计算器的开发和验证。
我们的目的是基于临床特征,包括假定的前驱症状,建立并验证精神科住院青少年患双相情感障碍(BSD)的风险评估模型。非精神病性/非bsd诊断的青少年住院患者(年龄= 12-18岁)被招募参加青少年情绪障碍和精神病研究(AMDPS),这是一个纵向的、前瞻性的5年随访队列。我们使用经过验证的双相前驱症状访谈和前瞻性量表评估了基线时综合征/亚综合征精神病理学的患病率和严重程度。我们进行了机器学习分析(Lasso-Cox回归分析,LCR),以创建一个计算器,根据基线人口统计学/合并症/疾病/治疗特征估计发生BSD的风险。105例青少年(年龄= 15.6±1.3岁,女性= 72.4%)中,18例发生BSD。在1/2/3/4年时,BSD的累积估计风险为5/22/29/36%。BSD的发展与持续性抑郁障碍的存在相关(HR = 4.0, p
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Psychiatry
Molecular Psychiatry 医学-精神病学
CiteScore
20.50
自引率
4.50%
发文量
459
审稿时长
4-8 weeks
期刊介绍: Molecular Psychiatry focuses on publishing research that aims to uncover the biological mechanisms behind psychiatric disorders and their treatment. The journal emphasizes studies that bridge pre-clinical and clinical research, covering cellular, molecular, integrative, clinical, imaging, and psychopharmacology levels.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信